A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

Clinical trial NCT03766581 · COMPLETED

Trial details

NCT number: NCT03766581
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke Transient Ischemic Attack (TIA)

Start date: 2019-01-27
Primary completion: 2022-03-31
Enrollment: 2366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.